LabGenomics Co., Ltd. (KOSDAQ:084650)

South Korea · Delayed Price · Currency is KRW

1,293.00

+19.00 (1.49%)

Apr 3, 2026, 3:30 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Medical Diagnosis			72.84B	144.57B
Medical Diagnosis Growth			-49.62%	-
Venture Start-Up Investment			291.33M	199.59M
Venture Start-Up Investment Growth			45.96%	-
Total			73.13B	144.77B
Total Growth			-49.49%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
South Korea			50.39B	129.30B	131.90B	51.28B	32.14B
South Korea Growth			-61.03%	-1.97%	157.21%	59.53%	-
Asia			661.34M	11.83B	61.33B	50.47B	689.56M
Asia Growth			-94.41%	-80.71%	21.53%	7219.16%	-
America			21.58B	2.77B	1.32B	12.70B	-
America Growth			677.91%	109.48%	-89.57%	-	-
Europe			498.99M	776.93M	1.40B	3.12B	340.72M
Europe Growth			-35.77%	-44.40%	-55.27%	817.01%	-
Other			-	91.79M	6.45B	1.90B	218.00K
Other Growth			-	-98.58%	238.80%	873683.49%	-
Total			73.13B	144.77B	202.41B	119.48B	33.18B
Total Growth			-49.49%	-28.47%	69.41%	260.14%	-

Source: S&P Global Market Intelligence.